Literature DB >> 19732312

Penile sonographic and clinical characteristics in men with Peyronie's disease.

James F Smith1, William O Brant, Vincent Fradet, Alan W Shindel, Eric Vittinghoff, Thomas Chi, Yun-Ching Huang, Cole B Davis, Simon Conti, Tom F Lue.   

Abstract

INTRODUCTION: Ultrasonography of the penis is readily available to the urologist and gives good anatomic detail of soft tissue structures. It has not been widely utilized in the assessment of Peyronie's disease (PD). AIMS: To describe the sonographic characteristics of the penis in PD and the relationship between clinical and sonographic features.
METHODS: This cross-sectional study enrolled patients from a single clinical practice. A PD-specific questionnaire was administered and sonographic evaluations were performed. MAIN OUTCOME MEASURES: Sonographic characteristics of men with PD.
RESULTS: Tunical thickening, calcifications, septal fibrosis, and intracavernosal fibrosis, were observed at initial clinical evaluation in 50%, 31%, 20%, and 15% of men, respectively. Men aged 40-49 (OR 2.4, P = 0.02) and men aged 50-59 (OR 2.4, P = 0.004) were more likely to have sub-tunical calcifications relative to men under age 40. Men with septal fibrosis had fewer chronic medical conditions such as diabetes (OR 0.3, P = 0.04), hypertension (OR 0.5, P = 0.03), and coronary artery disease (OR 0.2, P = 0.05), and presented within 1 year of disease onset (OR 2.1, P = 0.001). Men with septal fibrosis were less likely to have lost penile length (OR 0.5, P = 0.04) and more likely to be able to have intercourse (OR 1.9, P = 0.05). Men with intracavernosal fibrosis were less likely to have penile pain (OR 0.5, P = 0.05), but more likely to have penetration difficulty during intercourse (OR 1.9, P = 0.008), an additional penile deformity (OR 1.8, P = 0.02), or rapid onset of disease (OR 1.7, P = 0.04). Tunical thickening was associated with a decreased ability to have intercourse (OR 2.3, P < 0.001).
CONCLUSION: PD is a clinically and sonographically heterogeneous condition. Sonography is a safe, low-cost, and rapid means of objectively characterizing lesions in this condition. This may help track the evolution of the condition in individual patients and in the future may be useful for tailoring treatment strategies.

Entities:  

Mesh:

Year:  2009        PMID: 19732312     DOI: 10.1111/j.1743-6109.2009.01438.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  8 in total

1.  Peyronie's Disease: Nonsurgical Therapy Options.

Authors:  Franklin E Kuehhas; Peter Weibl; Tosev Georgi; Nenad Djakovic; Ralf Herwig
Journal:  Rev Urol       Date:  2011

2.  Are sonographic characteristics associated with progression to surgery in men with Peyronie's disease?

Authors:  Benjamin N Breyer; Alan W Shindel; Yun-Ching Huang; Michael L Eisenberg; Dana A Weiss; Tom F Lue; James F Smith
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

3.  2018 Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature.

Authors:  Anthony J Bella; Jay C Lee; Ethan D Grober; Serge Carrier; Francois Benard; Gerald B Brock
Journal:  Can Urol Assoc J       Date:  2018-02-22       Impact factor: 1.862

4.  The direction and severity of penile curvature does not have an impact on concomitant vasculogenic erectile dysfunction in patients with Peyronie's disease.

Authors:  E C Serefoglu; L Trost; S C Sikka; W J G Hellstrom
Journal:  Int J Impot Res       Date:  2014-07-17       Impact factor: 2.896

5.  Commentary on the myths of Peyronie's disease.

Authors:  Alex K Wu; Tom F Lue
Journal:  Transl Androl Urol       Date:  2012-12

6.  Evaluation of the Causes of Erectile Dysfunction in Patients Undergoing Penile Doppler Ultrasonography in Pakistan.

Authors:  Usman Khanzada; Sohail Ahmed Khan; Munawar Hussain; Hatem Adel; Kamran Masood; Syed Omair Adil; Murli Manohar
Journal:  World J Mens Health       Date:  2017-04       Impact factor: 5.400

7.  Ultrasound on Erect Penis Improves Plaque Identification in Patients With Peyronie's Disease.

Authors:  Yu Liu; Dequan Zheng; Xiaolin Liu; Xiaohong Shi; Shengchun Shu; Jinbing Li
Journal:  Front Pharmacol       Date:  2019-04-04       Impact factor: 5.810

8.  Structured Self-Rated Response to Iontophoresis with Verapamil and Dexamethasone in Peyronie's Disease.

Authors:  Abas Kokab; Kevan Wylie; Patricia Allen; Abhijeeth Shetty; Debbie Davies-South
Journal:  Adv Urol       Date:  2014-04-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.